Top Markets
#1 Zora Zora +33.25%
#2 Seeker Seeker +23.58%
#3 Axelar Axelar +22.71%
#4 AI XOVIA AI XOVIA +20.93%
#5 Full Moon Full Moon +18.72%
#6 0G 0G +16.10%
#7 Notcoin Notcoin +13.08%
#8 rsERG rsERG +10.58%
#9 VVS Finance VVS Finance +10.41%
#10 Cryptopia Cryptopia +10.26%
Coin of the day
Zora Zora
Настройки
Язык
Pусский
Валюта
USD
Тема
Eikon Therapeutics, Inc. Common Stock Eikon Therapeutics, Inc. Common Stock

Eikon Therapeutics, Inc. Common Stock

EIKN
Ранг среди акций #12325
Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established... Eikon Therapeutics, Inc. is a clinical biopharmaceutical company, established in 2019 and headquartered in Millbrae, California, operating within the United States. The company is dedicated to developing groundbreaking medicines to address significant unmet medical needs. It utilizes a proprietary platform capable of precisely characterizing protein interactions inside living cells. Eikon's drug pipeline includes EIK1001, a systemically delivered TLR 7/8 dual-agonist designed to activate both innate and adaptive anti-cancer immune responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors for ovarian, breast, prostate, and pancreatic cancers. Notably, EIK1004 is brain-penetrant, offering a therapeutic approach for brain metastases and primary brain malignancies. Additionally, EIK1005 is a potent WRN helicase inhibitor and anti-tumor agent aimed at MSI-high tumors, alongside EIK1006.
Цена акции
$11.03
Последняя синхронизация: 2026-08-28
Рыночная капитализация
$597.15M
Изменение (1 день)
-4.25%
Изменение (1 год)
-
Страна
US
Торговля Eikon Therapeutics, Inc. Common Stock (EIKN)

Категория

Healthcare
Коэффициент P/B для Eikon Therapeutics, Inc. Common Stock (EIKN)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Eikon Therapeutics, Inc. Common Stock, текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Eikon Therapeutics, Inc. Common Stock с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 2.5054 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 3.7087 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH